Nirmala D. Sirisena

1.3k total citations
54 papers, 504 citations indexed

About

Nirmala D. Sirisena is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Nirmala D. Sirisena has authored 54 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 17 papers in Molecular Biology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Nirmala D. Sirisena's work include BRCA gene mutations in cancer (10 papers), Genomics and Rare Diseases (8 papers) and Prenatal Screening and Diagnostics (7 papers). Nirmala D. Sirisena is often cited by papers focused on BRCA gene mutations in cancer (10 papers), Genomics and Rare Diseases (8 papers) and Prenatal Screening and Diagnostics (7 papers). Nirmala D. Sirisena collaborates with scholars based in Sri Lanka, United States and United Kingdom. Nirmala D. Sirisena's co-authors include Vajira H. W. Dissanayake, C. S. Paththinige, Nilakshi Samaranayake, Rohan W. Jayasekara, Adebowale Adeyemo, T. Kumanan‬, Prabha H. Andraweera, Chula Herath, Trond P. Leren and Oliver Brandau and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Psychology and BioMed Research International.

In The Last Decade

Nirmala D. Sirisena

51 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nirmala D. Sirisena Sri Lanka 12 153 144 74 64 59 54 504
Sofia Christakoudi United Kingdom 13 164 1.1× 99 0.7× 79 1.1× 71 1.1× 74 1.3× 31 565
Sandra Rodríguez‐Rodero Spain 17 214 1.4× 81 0.6× 72 1.0× 46 0.7× 47 0.8× 23 729
Dana Dlouhá Czechia 17 230 1.5× 179 1.2× 93 1.3× 119 1.9× 158 2.7× 49 678
Azim Nejatizadeh Iran 14 102 0.7× 58 0.4× 103 1.4× 47 0.7× 59 1.0× 57 475
Swati Ghosh India 13 214 1.4× 75 0.5× 90 1.2× 89 1.4× 53 0.9× 26 522
Elena P. Sorokin United Kingdom 14 284 1.9× 208 1.4× 159 2.1× 62 1.0× 77 1.3× 29 733
Fuyan Sun Japan 10 204 1.3× 125 0.9× 92 1.2× 79 1.2× 75 1.3× 18 501
Andrew Y. F. Li Yim Netherlands 11 168 1.1× 172 1.2× 65 0.9× 76 1.2× 31 0.5× 27 544
Didier Chevenne France 12 193 1.3× 130 0.9× 83 1.1× 82 1.3× 68 1.2× 30 598
Lingqing Hu China 15 208 1.4× 56 0.4× 80 1.1× 49 0.8× 25 0.4× 24 577

Countries citing papers authored by Nirmala D. Sirisena

Since Specialization
Citations

This map shows the geographic impact of Nirmala D. Sirisena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nirmala D. Sirisena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nirmala D. Sirisena more than expected).

Fields of papers citing papers by Nirmala D. Sirisena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nirmala D. Sirisena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nirmala D. Sirisena. The network helps show where Nirmala D. Sirisena may publish in the future.

Co-authorship network of co-authors of Nirmala D. Sirisena

This figure shows the co-authorship network connecting the top 25 collaborators of Nirmala D. Sirisena. A scholar is included among the top collaborators of Nirmala D. Sirisena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nirmala D. Sirisena. Nirmala D. Sirisena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ranasinghe, Priyanga, et al.. (2025). Pharmacogenomic profiling of variants affecting efficacy and toxicity of anti-infective medicines in a south Asian population from Sri Lanka. BMC Infectious Diseases. 25(1). 153–153. 1 indexed citations
3.
Tennakoon, Aruni, et al.. (2025). WCN25-1066 RENAL GLYCOSURIA DUE TO SLC5A2 MUTATION IN A CHILD PRESENTING WITH RECURRENT URINARY TRACT INFECTIONS AND FAILURE TO THRIVE. SHILAP Revista de lepidopterología. 10(2). S351–S352.
4.
6.
Sirisena, Nirmala D., et al.. (2023). Breast cancer surveillance in BRCA positive Sri Lankan women: health equity for a high-risk group at a limited resource setting. BMC Women s Health. 23(1). 636–636. 1 indexed citations
7.
Sirisena, Nirmala D., et al.. (2023). Associations of meditation with telomere dynamics: a case–control study in healthy adults. Frontiers in Psychology. 14. 1222863–1222863. 1 indexed citations
8.
Sirisena, Nirmala D., et al.. (2022). Design and implementation of a novel pharmacogenetic assay for the identification of the CYP2D6*10 genetic variant. BMC Research Notes. 15(1). 104–104. 2 indexed citations
9.
Nagy, Sara, Ehsan Ghayoor Karimiani, Bobby G. Ng, et al.. (2022). A recurrent homozygous missense DPM3 variant leads to muscle and brain disease. Clinical Genetics. 102(6). 530–536. 5 indexed citations
10.
Sirisena, Nirmala D., Osório Lopes Abath Neto, A. Reghan Foley, et al.. (2021). A novel variant in the COL6A1 gene causing Ullrich congenital muscular dystrophy in a consanguineous family: a case report. BMC Neurology. 21(1). 105–105. 1 indexed citations
11.
Sirisena, Nirmala D., Kajal Biswas, Teresa Sullivan, et al.. (2020). Functional evaluation of five BRCA2 unclassified variants identified in a Sri Lankan cohort with inherited cancer syndromes using a mouse embryonic stem cell-based assay. Breast Cancer Research. 22(1). 43–43. 5 indexed citations
12.
Sirisena, Nirmala D. & Vajira H. W. Dissanayake. (2019). Strategies for Genomic Medicine Education in Low- and Middle-Income Countries. Frontiers in Genetics. 10. 944–944. 11 indexed citations
14.
Sirisena, Nirmala D., Nana‐Maria Grüning, Oliver Brandau, et al.. (2018). Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report. BMC Medical Genetics. 19(1). 85–85. 18 indexed citations
16.
Paththinige, C. S., Nirmala D. Sirisena, & Vajira H. W. Dissanayake. (2017). Genetic determinants of inherited susceptibility to hypercholesterolemia – a comprehensive literature review. Lipids in Health and Disease. 16(1). 103–103. 81 indexed citations
17.
Sirisena, Nirmala D. & Vajira H. W. Dissanayake. (2017). Focusing attention on ancestral diversity within genomics research: a potential means for promoting equity in the provision of genomics based healthcare services in developing countries. Journal of Community Genetics. 8(4). 275–281. 9 indexed citations
18.
Sirisena, Nirmala D., et al.. (2016). HLA-B27 allele frequency in Sri Lankan patients with spondyloarthritides. Ceylon Medical Journal. 61(2). 71–71. 2 indexed citations
19.
Sirisena, Nirmala D., et al.. (2014). The Prevalence of the Prothrombin (F2) 20210G>A Mutation in a Cohort of Sri Lankan Patients with Thromboembolic Disorders. Indian Journal of Hematology and Blood Transfusion. 31(3). 356–361. 3 indexed citations
20.
Sirisena, Nirmala D., et al.. (2003). CD4+ T-lymphocyte counts in patients with human immunodeficiency virus type 1 (HIV-1) and healthy population in Jos, Nigeria. Nigerian Postgraduate Medical Journal. 10(3). 135–135. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026